$635 Million is the total value of Broadfin Capital, LLC's 45 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OVAS | Exit | OVASCIENCE INC | $0 | – | -545,282 | -100.0% | -0.07% | – |
| CFRX | Exit | CONTRAFECT CORP | $0 | – | -389,475 | -100.0% | -0.10% | – |
| IVTY | Exit | INVUITY INC | $0 | – | -298,800 | -100.0% | -0.18% | – |
| CDTX | Exit | CIDARA THERAPEUTICS INC | $0 | – | -375,816 | -100.0% | -0.23% | – |
| TTPH | Exit | TETRAPHASE PHARMACEUTICALS I | $0 | – | -1,048,642 | -100.0% | -0.50% | – |
| VCYT | Exit | VERACYTE INC | $0 | – | -600,658 | -100.0% | -0.52% | – |
| NVTA | Exit | INVITAE CORP | $0 | – | -750,000 | -100.0% | -0.55% | – |
| VAR | Exit | VARIAN MED SYS INC | $0 | – | -30,000 | -100.0% | -0.57% | – |
| PGNX | Exit | PROGENICS PHARMACEUTICALS INcall | $0 | – | -500,000 | -100.0% | -0.58% | – |
| NTUS | Exit | NATUS MEDICAL INC DEL | $0 | – | -113,526 | -100.0% | -0.60% | – |
| HZNP | Exit | HORIZON PHARMA PLCcall | $0 | – | -300,000 | -100.0% | -0.66% | – |
| OXFD | Exit | OXFORD IMMUNOTEC GLOBAL PLC | $0 | – | -374,233 | -100.0% | -0.73% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -166,500 | -100.0% | -0.81% | – |
| PRTK | Exit | PARATEK PHARMACEUTICALS INC | $0 | – | -477,607 | -100.0% | -0.97% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -2,078,799 | -100.0% | -0.98% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -86,786 | -100.0% | -0.98% | – |
| VCEL | Exit | VERICEL CORP | $0 | – | -658,900 | -100.0% | -1.02% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -130,900 | -100.0% | -1.11% | – |
| CI | Exit | CIGNA CORPORATION | $0 | – | -42,600 | -100.0% | -1.11% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -79,200 | -100.0% | -1.28% | – |
| GKOS | Exit | GLAUKOS CORP | $0 | – | -293,900 | -100.0% | -1.41% | – |
| AMAG | Exit | AMAG PHARMACEUTICALS INC | $0 | – | -598,800 | -100.0% | -1.88% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -258,292 | -100.0% | -2.10% | – |
| ANGO | Exit | ANGIODYNAMICS INC | $0 | – | -911,707 | -100.0% | -2.45% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -175,030 | -100.0% | -3.07% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Broadfin Healthcare Master Fund Ltd #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIODELIVERY SCIENCES INTL IN | 27 | Q4 2019 | 4.8% |
| HERON THERAPEUTICS INC | 24 | Q4 2019 | 9.0% |
| LA JOLLA PHARMACEUTICAL CO | 24 | Q4 2019 | 7.7% |
| RECRO PHARMA INC | 24 | Q4 2019 | 4.1% |
| ANTARES PHARMA INC | 24 | Q3 2019 | 3.4% |
| RETROPHIN INC | 23 | Q3 2019 | 7.0% |
| ARATANA THERAPEUTICS INC | 22 | Q2 2019 | 8.1% |
| MIRATI THERAPEUTICS INC | 22 | Q1 2019 | 7.9% |
| CATALYST PHARM PARTNERS INC | 22 | Q3 2019 | 6.2% |
| ANGIODYNAMICS INC | 21 | Q3 2018 | 6.6% |
View Broadfin Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Eiger BioPharmaceuticals, Inc.Sold out | January 04, 2021 | 0 | 0.0% |
| LA JOLLA PHARMACEUTICAL COSold out | January 04, 2021 | 0 | 0.0% |
| STRATA Skin Sciences, Inc. | June 23, 2020 | 1,529,392 | 4.5% |
| Teligent, Inc.Sold out | February 25, 2020 | 0 | 0.0% |
| Neos Therapeutics, Inc.Sold out | February 14, 2020 | 0 | 0.0% |
| Aclaris Therapeutics, Inc. | February 13, 2020 | 1,888,039 | 4.6% |
| Adamas Pharmaceuticals IncSold out | February 13, 2020 | 0 | 0.0% |
| ADMA BIOLOGICS, INC.Sold out | February 13, 2020 | 0 | 0.0% |
| AVADEL PHARMACEUTICALS PLC | February 13, 2020 | 1,029,012 | 2.8% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 13, 2020 | 0 | 0.0% |
View Broadfin Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2022-03-22 |
| 4 | 2022-02-15 |
| 4 | 2022-01-31 |
| 4 | 2021-11-22 |
| 4 | 2021-11-15 |
| 4 | 2021-11-09 |
| 4 | 2021-08-10 |
| 4 | 2021-05-13 |
| SC 13G/A | 2021-01-04 |
| SC 13G/A | 2021-01-04 |
View Broadfin Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.